Arazy Group Consultants Inc.

Arazy Group Consultants Inc.

Medical Equipment Manufacturing

Vancouver, BC 5,173 followers

Medtech Regulatory Affairs Technology explicitly designed for Regulatory Affairs Professionals like you!

About us

Arazy Group Consultants Inc. is the inventor of global medtech registration technology providing services and products designed to streamline, simplify, and expedite international market access affairs for all types of medical and IVD devices. With the launch of LICENSALE® - Global Medtech Registration System in 2013, Arazy Group took the lead on the provision of advanced registration and license management technology solutions, designed specifically for the medical and IVD device industry. Staying true to its company mission to make the best medical devices and medical practice available to patient and physicians around the world, LICENSALE® delivered thousands of new products registrations, amendments, renewals, and transfers of licenses over the past seven years. Leveraging on their experience and the latest advancement in software, database management, machine learning and A.I., Arazy Group developed the next generation in MedTech registration and license management software- LICENSALE® 2.0, REGISLATE® and the EUDAMEDtech© system Advanced solutions rapidly adopted by the global medtech industry and becoming the gold standard of market access license management. Arazy Group is based in Vancouver, British Columbia, Canada. Arazy Group has additional offices in the US, Argentina, Israel, Turkey, Korea and throughout Europe and is operating globally in 140 countries. Please contact us for more information or visit our website: http://arazygroup.com.

Website
http://www.arazygroup.com/l
Industry
Medical Equipment Manufacturing
Company size
51-200 employees
Headquarters
Vancouver, BC
Type
Privately Held
Founded
1995
Specialties
Global Medical Device Registration, Medical Device Safety Compliance, Quality Management System, Universal Representation & Administration, Clinical & Medical Research, Cloud technologies, Regulatory Affairs, Regulatory Affairs Technology, consulting, and Regulatory Affairs Consulting

Products

Locations

Employees at Arazy Group Consultants Inc.

Updates

  • Arazy Group Consultants Inc. reposted this

    ✨ Merry Christmas from All of Us at Arazy Group! As the year comes to a close, we want to thank our incredible clients, partners, and team members for making 2024 a year of progress and innovation. We wish you joy, peace, and cherished moments with loved ones this holiday season. May your celebrations be bright and your new year filled with success and opportunity! Here’s to a thriving 2025 together. 🌟

  • ✨ Merry Christmas from All of Us at Arazy Group! As the year comes to a close, we want to thank our incredible clients, partners, and team members for making 2024 a year of progress and innovation. We wish you joy, peace, and cherished moments with loved ones this holiday season. May your celebrations be bright and your new year filled with success and opportunity! Here’s to a thriving 2025 together. 🌟

  • Medica vs. Arab Health: What’s the Best Fit for You? Last on your "2024 To Do List," Decide if you're going to Arab Health. You need to know how Arab Health stacks up against Medica for sales and growth. Our latest blog dives into the details, comparing these two premier events and what they mean for your MedTech business. Spoiler alert: they’re both powerhouses, but your choice depends on your goals. https://hubs.ly/Q030hZhB0 And if you’re heading to Arab Health 2025, we’d love to meet! As your trusted partner in Global Market Access, Arazy Group combines 30 years of expertise with cutting-edge RegTech solutions to unlock your international potential. https://hubs.ly/Q030hZkq0 #MedTech #MedicalDevices #GlobalMarketAccess #ArabHealth2025 #Medica2024 #HealthTech #RegulatoryAffairs #MedicalInnovation #TradeShows #BusinessGrowth

    • No alternative text description for this image
  • The Indonesian Ministry of Health issued Circular Letter No. HK.02.02/E/1753/2024 on September 9, 2024, introducing a significant update for the medical device industry. Starting January 1, 2025, Good Distribution Practice (GDP) certificates will become mandatory for listing medical devices in the Electronic Catalog System. This step aligns with Government Regulation No. 28 of 2024 under Law No. 17 of 2023 concerning Health, ensuring safety, quality, and efficacy. Want to learn more? Visit our YouTube channel for insights and updates on key regulatory changes like this one: https://hubs.ly/Q030hTtx0 Or if you just want to chat with an experienced regulatory consultant...ask us anything, we’re really friendly😊! https://hubs.ly/Q030hTsz0 #MedicalDevices #RegulatoryUpdates #GoodDistributionPractice #Indonesia #YouTube The full report: https://hubs.ly/Q030hV0b0

    • No alternative text description for this image
  • Thank you to everyone who attended the final RegTalk of 2024 this morning! It was an engaging and insightful session, and we truly appreciate your participation and support throughout the year. For those who couldn’t make it, the recording will be available on our YouTube channel in a few days. In the meantime, feel free to explore past videos and catch up on all the valuable content we've shared so far! https://hubs.ly/Q02__6yC0 Thank you again, and we look forward to connecting with you in the new year! #RegTalk #Webinar #ThankYou #2024 #RegulatoryUpdates #YouTube

    • No alternative text description for this image
  • 📈 Important Public Consultation: EU MDR & IVDR Evaluation The European Commission has launched a public consultation and call for evidence regarding the targeted evaluation of the EU Medical Device Regulation (MDR) and the In Vitro Diagnostic Regulation (IVDR). As an experienced professional in EU regulatory affairs, I cannot stress enough how critical this initiative is for all medical device and IVD stakeholders. Key Details: • The consultation is live and open for input until March 21, 2025. • It offers a unique opportunity for manufacturers, notified bodies, healthcare professionals, and other stakeholders to share valuable insights and evidence regarding the practical implementation and real-world impact of the MDR and IVDR. Why Your Input Matters: The EU MDR and IVDR have brought significant changes to our industry, but they have also presented challenges, including: ✔️Limited availability of notified bodies ✔️Transition timelines causing uncertainties ✔️Potential Device Shortages That Impact Patient Care This consultation will highlight these challenges and propose solutions that could influence the Commission’s evaluation. Your feedback may play a role in shaping future amendments, guidance, or actions to streamline MDR and IVDR compliance. 👉Who Should Participate? Your input can make a difference if you are a manufacturer, notified body, healthcare provider, or other key stakeholder. Now is the time to contribute your expertise, share your challenges, and help refine the regulatory framework for the future. Let’s work together to ensure the regulations continue to protect patient safety while supporting innovation and access to essential medical devices and diagnostics in Europe. 📊 Act Now: Provide Your Input Before March 21, 2025. Questions? Reach out to our EU Experts today: https://hubs.ly/Q02_Sbrn0 #EUMDR #EURegulations #IVDR #MedicalDevices #RegulatoryAffairs #EUCommission #PublicConsultation #MedTech

    • No alternative text description for this image
  • 🎉🎊Exclusive Regulatory Affairs Event – Don’t Miss Out! Join Imane Jemal, Regulatory Affairs Expert, for an exclusive open-access session on the latest updates in the medical device and IVD industry! Imane Jemal, a seasoned professional in scientific and regulatory affairs, brings nearly 30 years of expertise in global regulatory frameworks. As Project Manager and Medical & IVD Device Regulatory Affairs Expert at Arazy Group, Imane leads strategic client support, regulatory intelligence, and registration projects. Fluent in Arabic, French, English, and Spanish, she offers a truly global perspective on the evolving regulatory landscape. 🔹 Why should you join this event? ✔️Exclusive access to industry-leading regulatory expertise ✔️A comprehensive review of the most significant regulatory updates of 2024 ✔️Expert analysis on how these changes have shaped the industry ✔️Forward-looking predictions to prepare for 2025 and beyond As we close out 2024, this live event will provide actionable insights on how regulatory changes are impacting the MedTech industry, offering you the strategic tools to stay ahead in the ever-changing landscape. 📅 Event Details: Date: Tuesday, December 17, 2024 Time: 7:00 – 7:45 AM PST 🔗 Register Now and secure your spot in this must-attend session! https://hubs.ly/Q02_Fb1x0 #RegulatoryAffairs #MedicalDevices #IVD #RegulatoryIntelligence #GlobalRegulations #MedTech #RegulatoryUpdates #ArazyGroup #IndustryInsights #RegulatoryAffairsExperts

    • No alternative text description for this image
  • Unlock Your MedTech Potential: Why Arab Health Could Be Your Game-Changer! On this Friday, the 13th, let’s leave superstition behind—success in the MedTech industry is built on strategy, not luck. Choosing the right platform to showcase innovation can make all the difference for small to medium-sized medical device companies. Arab Health vs. Medica—what’s the real edge? Our latest blog dives deep into this comparison and highlights why Arab Health could be the turning point for your business. ✨ Why Arab Health? ✔️ Access Emerging Markets: MENASA’s booming healthcare sector offers unparalleled opportunities. ✔️ Engage Decision-Makers Directly: Build partnerships with key stakeholders for faster market entry. ✔️ Spotlight Innovation: From AI diagnostics to telemedicine, this is where cutting-edge tech meets demand. ✔️ Sustainability Focus: Lead the way in consumer-centric, sustainable healthcare solutions. 💡 Don’t get lost in the crowd. Medica might be the world’s largest fair, but smaller players often find it challenging to shine. Arab Health’s strategic focus creates the perfect stage for companies ready to make an impact. 👉 Are you curious to know how this can transform your market strategy? Check out the full blog here for insights that could redefine your growth trajectory. https://hubs.ly/Q02_FqcF0 🛠 Pro Tip: Breaking into new markets isn’t easy—but it doesn’t have to be daunting. Arazy Group is here to guide you through global compliance and market entry. Start your journey today—no luck needed! 🍀 #MedTech #HealthcareInnovation #ArabHealth2024 #EmergingMarkets #MedicalDevices #HealthTech #SustainabilityInHealthcare #GlobalHealthcare #MarketExpansion #FridayThe13th

    • No alternative text description for this image
  • 🎉🎊Exclusive Regulatory Affairs Event – Don’t Miss Out! Join Imane Jemal, Regulatory Affairs Expert, for an exclusive open-access session on the latest updates in the medical device and IVD industry! Imane Jemal, a seasoned professional in scientific and regulatory affairs, brings nearly 30 years of expertise in global regulatory frameworks. As Project Manager and Medical & IVD Device Regulatory Affairs Expert at Arazy Group, Imane leads strategic client support, regulatory intelligence, and registration projects. Fluent in Arabic, French, English, and Spanish, she offers a truly global perspective on the evolving regulatory landscape. 🔹 Why should you join this event? ✔️Exclusive access to industry-leading regulatory expertise ✔️A comprehensive review of the most significant regulatory updates of 2024 ✔️Expert analysis on how these changes have shaped the industry ✔️Forward-looking predictions to prepare for 2025 and beyond As we close out 2024, this live event will provide actionable insights on how regulatory changes are impacting the MedTech industry, offering you the strategic tools to stay ahead in the ever-changing landscape. 📅 Event Details: Date: Tuesday, December 17, 2024 Time: 7:00 – 7:45 AM PST 🔗 Register Now and secure your spot in this must-attend session! https://hubs.ly/Q02_y02D0 #RegulatoryAffairs #MedicalDevices #IVD #RegulatoryIntelligence #GlobalRegulations #MedTech #RegulatoryUpdates #ArazyGroup #IndustryInsights #RegulatoryAffairsExperts

    • No alternative text description for this image

Similar pages

Funding